The current valuation score of Cellectar Biosciences Inc is 6.95, ranking 142 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -0.52, which is -130.59% below the recent high of 0.16 and -54.07% above the recent low of -0.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.